First Niagara Bank’s Biogen BIIB Stock Holding History

First Niagara Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$580K	Sell	2,400 -1	-0%	-$264	0.17%	110
2016 Q1	$625K	Buy	2,401 +139	+6%	+$36.7K	0.18%	107
2015 Q4	$693K	Buy	2,262 +281	+14%	+$80.7K	0.19%	104
2015 Q3	$578K	Buy	1,981 +15	+0.8%	+$4.95K	0.15%	124
2015 Q2	$794K	Sell	1,966 -57	-3%	-$22.9K	0.18%	109
2015 Q1	$854K	Sell	2,023 -454	-18%	-$179K	0.19%	108
2014 Q4	$841K	Buy	2,477 +30	+1%	+$9.71K	0.18%	108
2014 Q3	$809K	Hold	2,447	–	–	0.17%	112
2014 Q2	$772K	Hold	2,447	–	–	0.16%	118
2014 Q1	$748K	Hold	2,447	–	–	0.15%	125
2013 Q4	$684K	Hold	2,447	–	–	0.13%	132
2013 Q3	$589K	Hold	2,447	–	–	0.13%	136
2013 Q2	$527K	Buy	+2,447	New	+$523K	0.11%	146

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Niagara Bank's BIIB Position: Q2 2016 in Review

First Niagara Bank reduced its Biogen (BIIB) stake by 0.04% in Q2 2016, selling an estimated $264 and leaving 2,400 shares worth $580K. The position accounts for 0.17% of the portfolio, ranked #110.

First Niagara Bank first reported a position in BIIB in Q2 2013 and has held it in 13 quarters since. The position peaked at $854K in Q1 2015. 966 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

First Niagara Bank held 2,400 shares of Biogen worth $580K as of Q2 2016.
First Niagara Bank sold 1 Biogen share in Q2 2016, an estimated $264.
Biogen made up 0.17% of First Niagara Bank's portfolio in Q2 2016, its #110 holding.
First Niagara Bank first reported a position in Biogen in Q2 2013 and has held it in 13 quarters since.
First Niagara Bank's Biogen position peaked at $854K in Q1 2015.
966 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.